• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Leishmaniasis

Leishmaniasis - 70 Studies Found

Completed : Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia
: Cutaneous Leishmaniasis
: 2013-04-24
: Drug: Topical Amphotericin B at 3% Other Name: Anfoleish
Not yet recruiting : Miltefosine and GM-CSF in Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2016-12-27
:
  • Drug: Sbv Standard treatment f

Completed : Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2011-06-23
:
  • Drug: Pentoxifylline Patients

Completed : WR 279,396 for the Treatment of Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2013-11-14
: Drug: WR 279,396 Paromomycin + Gentamicin Topical Cream
Completed : Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis
: Cutaneous Leishmaniasis.
: 2016-03-04
:
  • Drug: Single dose of Pentacarinat®

Completed : Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2006-04-21
:
  • Drug: Meglumine antimoniate Me

Active, not recruiting : Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis
: Cutaneous Leishmaniasis
: 2011-02-20
: Drug: Meglumine antimoniate Meglumine antimoniate is store
Active, not recruiting : Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
: Cutaneous Leishmaniasis
: 2007-06-14
:
  • Drug: Miltefosine Oral Miltefo

Completed : Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama
: Cutaneous Leishmaniasis
: 2013-02-05
:
  • Drug: WR 279,396 WR 279,396 is

Completed : Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants
: Cutaneous Leishmaniasis
: 1999-11-03
: Biological: Combination of autoclaved leishmania antigen with recombinant human interleukin-12 (rhIL-12) and aluminum hydroxide gel as adjuvants
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.